Table4.

Demographic, Clinical and Paraclinical Comparison between Male Patients with and Without Depressive Symptoms (n = 367)^*

	Non-Depressed Male (n=256)	Depressed Male (n=111)	P Value
Age (y)	41.15±3.26	41.10±3.55	0.897
Risk Factors
Positive Family History	98 (38.3)	58 (52.3)	0.013
Hypertension	84 (32.8)	24 (21.6)	0.031
Hyperlipidemia	184 (71.9)	71 (64.0)	0.131
Diabetes Mellitus	41 (16.0)	19 (17.1)	0.793
Cigarette Smoking	155 (60.5)	83 (74.8)	0.009
Opium Usage	42 (16.4)	33 (29.7)	0.004
No Risk Factor	13 (5.1)	4 (3.6)	0.537
BMI (kg/m2)	27.95±3.98	28.50±3.95	0.227
BMI Categories			0.586
Underweight	1 (0.4)	0
Normal	57 (22.3)	19 (17.1)
Overweight	126 (49.2)	56 (50.5)
Obese	72 (28.1)	36 (32.4)
Creatinine (mg/dl)	1.03±0.20	1.04±0.22	0.649
EF (%)	51.65±10.02	49.97±9.96	0.156
Abdominal Circumference (cm)	98.02±9.31	98.39±9.53	0.726
Heart Failure	1 (0.4)	0	1.0
No of Involved Vessels			0.817
SVD	102 (39.8)	44 (39.6)
2VD	71 (27.7)	34 (30.6)
3VD	83 (32.4)	33 (29.7)
Left Main Coronary Involvement	2 (0.8)	2 (1.8)	0.387
Initial Treatment			0.101
Medical Treatment	77 (30.1)	26 (23.4)
PCI	122 (47.7)	49 (44.1)
CABG	57 (22.3)	36 (32.4)
CAD Duration (mo)	58.13±20.50	58.23±21.02	0.968
MACE	39 (15.2)	27 (24.3)	0.037

BMI, Body mass index; EF, Ejection fraction; MI, Myocardial infarction; SVD, Single-vessel disease; 2VD, Two-vessel disease; 3VD, Three-vessel disease; PCI, Percutaneous coronary intervention; CABG, Coronary artery bypass grafting; CAD, Coronary artery disease; MACE, Major cardiac adverse events

^* Data are presented as mean ±SD or n (%)